In pediatric psoriasis patients, lesions may differ in distribution and morphology, and their clinical symptoms at presentation may vary from those reported by adults.

There are currently no international standardized guidelines for medical treatment of pediatric psoriasis. Treatment is primarily based on published case series, guidelines for adult psoriasis, expert opinions and experience with these drugs in other pediatric disorders.

Pediatric psoriasis has a high impact on the quality of life of those affected.

There is increasing evidence suggesting an association of pediatric psoriasis with certain other morbidities, including hyperlipidemia, obesity, hypertension, diabetes mellitus and rheumatoid arthritis.